Q1 FY27 Results: Revenue up, ESOP grant, auditor change, KMP resignation

Revenue Growth 20pctResults View source PDF Explain this filing

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.8%Reaction day

₹1709.30

prior close

₹1711.10

announcement price

In-mkt

timing

Nifty Smallcap 250market-0.0%-0.8% vs market

Medical Equipment & Supplies peers, median of 12sector+0.0%-0.8% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.8

10m

-1.1

15m

-1.3

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.8-0.0-0.8+0.0-0.8

Next day

+3.7-0.1+3.8-0.5+4.2

+9.1+0.1+9.0-3.8+12.9

+9.9-0.1+10.0-2.4+12.3

+5.6+0.0+5.6-1.9+7.5

+4.3-0.4+4.8+0.0+4.3

+4.5-0.1+4.5-2.5+7.0

15d

+1.7+0.7+0.9-1.8+3.5

-0.1+0.7-0.8-4.0+4.0

-5.6-2.4-3.2-3.7-1.9

—————

UpDownMarket · Nifty Smallcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Poly Medicure Q1 FY27 standalone revenue Rs 43,110 lacs (vs Rs 38,405 YoY), PAT Rs 8,812 lacs vs Rs 8,793 YoY. Consolidated revenue Rs 52,538 lacs (up 30% YoY from Rs 40,321), PAT Rs 8,527 lacs vs Rs 9,308 YoY. Board approved 1,476 ESOP grants at Rs 100 per share, allotted 1,975 shares under ESOP 2020. Re-appointed Jai Prakash and Co as cost auditor for FY27. Deputy CS Ravi Prakash resigned effective Aug 10.

Likely market impact

Consolidated revenue growth of 30% YoY signals strong expansion, but PAT dipped. ESOP grants and KMP exit are routine.